Massachusetts Institute of Technology - MIT

Total investments

24

Average round size

10M

Portfolio companies

22

Rounds per year

0.15

Lead investments

6

Follow on index

0.08

Exits

3

Areas of investment
BiotechnologyEnergy StorageTransportationArtificial IntelligenceMachine LearningHealth CareManufacturingEnergyRenewable EnergyAgTech

Summary

Massachusetts Institute of Technology - MIT is the famous Corporate Investor, which was founded in 1861. The main office of represented Corporate Investor is situated in the Cambridge. The fund was located in North America if to be more exact in United States.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this Corporate Investor is 5 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Massachusetts Institute of Technology - MIT performs on 16 percentage points less the average number of lead investments. The high activity for fund was in 2018.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Solugen, Cambridge Innovation Center (CIC), RapidSOS The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Energy Storage, Biopharma. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Massachusetts Institute of Technology - MIT, startups are often financed by LocalGlobe, ADV, Y Combinator. The meaningful sponsors for the fund in investment in the same round are Sequoia Capital, Qualcomm, Procter & Gamble Company. In the next rounds fund is usually obtained by Refactor Capital, General Electric (GE), Founders Fund.

The current fund was established by Erastus Brigham Bigelow, Zen Chu.

Show more

Investments analytics

Analytics

Total investments
24
Lead investments
6
Exits
3
Rounds per year
0.15
Follow on index
0.08
Investments by industry
  • Renewable Energy (5)
  • Manufacturing (5)
  • Energy (4)
  • AgTech (3)
  • Machine Learning (3)
  • Show 51 more
Investments by region
  • United States (14)
  • India (2)
  • United Kingdom (2)
  • Kenya (1)
  • Nigeria (1)
  • Show 3 more
Peak activity year
2018
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
81M
Group Appearance index
0.62
Avg. company exit year
30
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Gaia AI 07 Dec 2022 Information Services, Artificial Intelligence, Computer Vision Seed 3M United States, Massachusetts, Somerville
Huake Tek 11 Jan 2020 Developer Tools, Computer, Nanotechnology Late Stage Venture 15M China, Guangdong Province, Futian District
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.